Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ICML 2019 | Precision epigenetic therapy for B-cell lymphoma

Ari Melnick • 20 Jun 2019
ICML 2019
B-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma

Ari Melnick, MD, Weill Cornell Medical College, New York, NY, discusses precision epigenetic therapy for B-cell lymphoma. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

More from Ari Melnick

3:59
The critical role of SIRT3 in lymphomagenesis
Ari Melnick • 20 Jun 2019
2:45
Epigenetic alleles: an emerging concept
Ari Melnick • 25 Feb 2019
5:24
Translating epigenetic therapy to the clinic: rational combinations
Ari Melnick • 24 Feb 2019
8:13
Acute leukemias discussion: what does genomics and epigenomics tell us about patient management?
Ari Melnick et al. • 2 Mar 2018

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals